bilirubin

Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma

...ncreased release of a liverenzyme known as ALT and bilirubin (an orange or yellowish pigmentin bile). As a result, the level of liver enzymes in patientstreated with ZYFLO CR and ZYFLO should be measured by a simpleblood test. It is recommended that physicians perform this testbefore administering ZYFLO CR and...

The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer

...tin(R) combination arm. The incidence of increased bilirubin was similar on both arms. Changes noted on li...t count and blood chemistries (including ALT, AST, bilirubin and creatinine) is recommended before each Eloxatin(R) cycle * The safety and effectiveness ...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

... (10%-31%); diarrhea (24%-30%);rash (24%-28%); and bilirubin (16%-26%). The most severe adverse events (grades 3/4) with GEMZAR pluscisplatin for the first-line treatment of patients with NSCLC wereneutropenia (57%-64%); thrombocytopenia (50%-55%); leukopenia(29%-46%); anemia (22%-25%); nausea (27%); vomiting...

Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research

...tin(R) combination arm. The incidence of increased bilirubin was similar on both arms. Changes noted on l...t count and blood chemistries (including ALT, AST, bilirubin and creatinine) is recommended before each Eloxatin(R) cycle -- The safety and effectivenes...

Baraclude (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

...cluded ALT elevation or hepatitis exacerbation(4), bilirubin elevation (1), inguinal hernia (1), sialoadenitis (1),thrombocytopenic purpura (1), groin pain (1), macular edema (1),urinary incontinence (1) and cholelithiasis (1). Two of these events,hepatitis exacerbation (1) and thrombocytopenia (1), were cons...

Study Presented at ACC Shows Treatment With ISIS 301012 Added to Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C Levels of Less Than 70 mg/dL

...hALT or ALT elevations together with elevations in bilirubin greaterthan 2xULN). Patients in this study remain in follow-up. According to John J.P. Kastelein, M.D., Ph.D., Chairman,Department of Vascular Medicine at the Academic Medical Center inAmsterdam, The Netherlands, lead investigator in the study, "ISI...